(Hypertension. 1995;26:465-470.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson.
| Abstract |
|---|
|
|
|---|
Key Words: obesity hemodynamics rabbits
| Introduction |
|---|
|
|
|---|
In general, studies of different forms of hypertension in nonobese animals show that cardiac output is either unchanged5 or decreased6 and that overall resistance is increased.5 6 Reduction in tissue blood flow is generally in proportion to the reduced cardiac output but may be more striking in the kidneys.5 6 In contrast, obesity-associated hypertension generally is associated with an increase in cardiac output.7 8 9 10 11 12 Rocchini13 speculated that the increased cardiac output is directed toward nonadipose vascular beds because of the relative avascularity of adipose tissue. However, although it was documented that flow did increase to some nonadipose tissue beds in obese dogs, flow to adipose tissue was not measured.14 Studies of flow to adipose and nonadipose tissues in animals have been performed but only either in normotensive and hypertensive animals without the complicating factor of obesity6 15 16 17 18 or in lean and obese animals without the effect of hypertension.19 Studies of adipose tissue flow in obesity in humans20 are limited by the lack of simultaneous measurement of nonadipose tissue flow. Thus, data are scarce on overall and regional flow and resistance alterations in obesity-associated hypertension. Therefore, the purpose of this study was to determine alterations in overall and regional flows and resistances in adipose and nonadipose tissues in a new model of obesity-associated hypertension in rabbits.
| Methods |
|---|
|
|
|---|
Experiments were conducted after an 8- to 12-week period of dietary manipulation. General anesthesia was induced in rabbits with 4% to 5% isoflurane with an oxygen flow of 1 L/min and was administered with a face mask. Anesthesia was maintained with 2% to 3% isoflurane. The right femoral artery was cannulated, and a catheter (PE-90) was advanced into the abdominal aorta for measurement of arterial blood pressure and withdrawal of a reference blood sample during the microsphere procedure. The right carotid artery was isolated and another catheter (PE-90) was advanced into the left ventricle for microsphere injection. The placement of this catheter tip in the ventricle was verified by observation of the ventricular pulse pressure. Bupivacaine (0.25%) was administered locally around both incision sites so that there would be no discomfort from the surgical incisions during the remainder of the experiment.
Protocol
Rabbits were allowed to recover from the anesthesia
for 1 to 1.5 hours while positioned in a Lucite rabbit restrainer (Plas
Labs). During this time the femoral arterial catheter was
connected to a pressure transducer to allow continuous
recording of arterial pressure and heart rate.
Signals from the transducer were sent to an analog-to-digital
convertor and analyzed with a personal computer and customized
software that has already been tested and implemented in this
laboratory.22 Heart rate and pressures were recorded
for 30 minutes after the recovery period; the averaged values over the
30 minutes were used for statistical analyses.
After blood pressure measurements cardiac output was determined with the use of radioactive microspheres (46Sc, 15±3 µm diameter, New England Nuclear) as described by Stanek et al.23 Briefly, dry microspheres were suspended in a 1.3specific gravity dextrose solution with one drop of 0.05% Tween 80, and a precoiled 70 cm length of PE-90 tubing was filled with 0.4 mL of the microsphere suspension. The microsphere injection coil was then interposed between the left ventricular catheter and an infusion pump (Gilford 105-S), and the femoral catheter was connected to a withdrawal pump. Reference sampling of arterial blood (2 mL/min) for cardiac output determination was started 10 seconds before the start of the microsphere infusion and ended 55 to 60 seconds after the infusion had been completed; sampling time for the withdrawal of the 3 mL of reference blood was recorded. Approximately 2x106 microspheres were injected over a period of approximately 20 seconds; the injection was followed by flushing of the infusion catheter with saline. The residual activity in the infusion coils and connectors was determined and subtracted from the preinjection activity for determination of the amount of activity injected.
After injection of the microspheres the rabbit was euthanized with an overdose of pentobarbital sodium. The heart ventricles, kidneys, lungs, diaphragm, liver, spleen, stomach, brain, ovaries, adrenals, large and small intestines, and selected fat depot samples were removed, separated immediately from extraneous fat and fibrous tissue, and weighed on a precision balance. Both the tissue samples and reference blood sample were then placed in glass vials and counted on a gamma counter (Searle 1185) for radioactivity determination. Radioactivity for the entire organ was directly determined for the right and left ventricles, kidneys, spleen, ovaries, and adrenals. For the lungs, liver, stomach, brain, and intestines, total organ weights were recorded, and then only a sample of the organ was counted for radioactivity. Total organ blood flows (milliliters per minute) and organ blood flows indexed for organ weight (milliliters per minute per gram) were calculated (see "Calculations" as follows).
Calculations
Cardiac output was calculated as
![]() |
![]() |
where
![]() |
![]() |
![]() |
Both absolute (milliliters per minute) and standardized (milliliters per minute per kilogram) cardiac output values were calculated.
For tissue blood flow calculations the number of microspheres in the tissue was calculated as the ratio of the number of microspheres in the sample to the sample weight times the total organ weight. Tissue blood flow per gram of tissue was calculated as the ratio of the number of microspheres in the selected organ to the total number of injected microspheres times total cardiac output and then divided by organ weight. Peripheral resistances were calculated by dividing mean arterial blood pressure (millimeters of mercury) by respective flows (milliliters per minute); resistances normalized for tissue weight were calculated by dividing mean arterial blood pressure by normalized tissue flow (milliliters per minute per gram).
Statistical Analyses
Right- and left-side organ weights and normalized tissue
flows were compared in the lungs, kidneys, adrenals, and ovaries using
paired t tests. Since there were no significant differences
in the variables measured (P>.05), right and left sides
were combined in further calculations and analyses.
Analyses of group differences between obese and lean rabbits
were then performed using unpaired t tests. All data are
expressed as mean±SEM; statistical significance was accepted at a
value of P
.05.
| Results |
|---|
|
|
|---|
.05) and mean
arterial pressure higher by 19% (P
.05) in the
obese rabbits (Table 1). Elevations in
both systolic and diastolic pressures contributed to the
rise in mean pressure. Resting heart rate was also higher by 23%
(P
.05). Blood pressure values recorded for both lean
and obese rabbits in the present experiment were slightly higher
than those recorded previously in this laboratory,24
probably because of the occlusion of the right carotid artery for
placement of the ventricular catheter.
|
Cardiac Output
Obesity-associated hypertension in the rabbits was accompanied
by a 37% increase in absolute resting cardiac output (812±59 and
593±47 mL/min, respectively; P
.05). When indexed for body
weight, however, cardiac output did not differ between groups,
averaging 156±11 mL/min per kilogram for the obese rabbits and 162±13
mL/min per kilogram for the lean rabbits. The increase in pressure in
the obese rabbits was proportionally less than the increase in cardiac
output, so that total peripheral resistance was 18% lower
for the obese rabbits (P
.05, Table 2).
Although resistance indexed for body weight tended to be higher (+21%)
in the obese rabbits, this failed to reach statistical significance
(P=.06, Table 2).
|
Regional Blood Flow
Increased body weight in the obese rabbits was accompanied by
increased weights of many of the body organs (Table 3). Both the right and left ventricles
were approximately 30% heavier in the obese rabbits, and kidneys were
approximately 24% heavier (P
.05). Other organs
demonstrating significant weight increase in the obese rabbits included
the liver (40%), ovaries (40%), adrenals (26%), diaphragm (15%),
and spleen (47%) (all P
.05). The increases in organ
weights were accompanied by higher absolute blood flows in some organs.
Right and left ventricular flows were higher in the obese
rabbits by 40% and 77%, respectively (P
.05); combined
flow to the kidneys was increased by 40% (P
.05). In
addition, absolute flow was higher in the lungs (+124%) and ovaries
(+50%) (P
.05).
|
After indexing for tissue weight, blood flow to the large intestine was
68% higher in the obese rabbits compared with the lean rabbits
(P
.05) (Table 3). Although
normalized blood flow tended to be higher in the obese rabbits in the
left ventricle (+35%, P=.06), kidneys (+12%,
P=.09), and lungs (+126%, P=.08), these values
did not reach statistical significance.
Blood flows in four selected fat depots are listed in Table 4. In all sites sampled the blood flow per gram of fat
tissue was significantly lower in the obese than lean rabbits (all
P
.05), with differences ranging from 55% to 73%.
Consequently, calculated tissue resistance was increased significantly
in three of the four fat depots, with increases ranging from 128% to
276%. Absolute resistances in other tissues (Table 2)
did not differ between lean and obese rabbits, except in the left
ventricle, kidneys, and large intestine, where resistances were 39%,
14%, and 27% lower, respectively, in the obese rabbits. When indexed
for organ weight the differences in the left ventricle and large
intestine were no longer significant. Although normalized kidney
resistance tended to be higher in the obese rabbits (+12%,
P=.09), this value did not reach statistical
significance.
|
| Discussion |
|---|
|
|
|---|
Overall and Regional Blood Flows and Resistances
Previous studies have shown that both weight gain and hypertension
are independently associated with alterations in overall and regional
blood flow. With obesity, in the presence or absence of concomitant
hypertension, absolute values of cardiac output are significantly
increased both in humans and in animal models4 7 8 9 10 11 12 19 25
and are usually associated with an increase in plasma volume. However,
in accord with the present findings, most research indicates that
cardiac output does not differ between lean and obese individuals when
it is indexed for body weight or body surface
area.4 7 10 11 13 19 25 26 In contrast, in the
ventromedial hypothalamic lesioned rat, obesity is not associated with
alterations in central hemodynamics despite significant
increases in blood pressure.27 28 This disparity with the
present findings may represent a species difference or may
be unique to the ventromedial hypothalamic method of producing obesity.
Alternatively, the differences may result from the comparatively
smaller increases in body weight and blood pressure produced in these
studies.
It has been stated that obese individuals have an increase in cardiac output out of proportion to the increase in fat mass, thus suggesting that blood flow to nonadipose tissue is increased.4 13 20 This has been verified in obese rats, in which increases in flow to the kidneys, liver, and testes have been documented,19 and in obese hypertensive dogs, in which renal blood flow has been shown to increase.10 A preliminary report also documented increases in flow to the gastrointestinal tract, heart, and brain in the obese dog model.14 In contrast, the ventromedial hypothalamic rat model demonstrated a decrease in the proportion of flow to the kidney in obesity-associated hypertension.27 The present study demonstrated that nonadipose flow in obesity-associated hypertension was significantly increased in the ventricles, kidneys, and large intestine. Even indexed for the increase in organ size, flow tended to be higher in the left ventricle and kidneys. The increase in flow to the left ventricle may be related in part to the greater metabolic work associated with the higher heart rate in the obese rabbits.
In the present study the increase in heart rate appeared to be responsible for most of the increase in cardiac output because the calculated stroke volume did not differ between lean and obese rabbits (2.7±0.6 and 3.1±0.7 mL, respectively). This is in accord with data from studies of obesity-associated hypertension in dogs,10 which demonstrated a 57% increase in heart rate concomitantly with a 56% increase in cardiac output. Data from obese adolescents8 and adults29 also suggest that elevations in heart rate, rather than in stroke volume, are associated with obesity-related increases in cardiac output. However, the literature is not entirely in agreement on the contributions of heart rate and stroke volume to the increased cardiac output, as there are assertions that the elevated cardiac output in obesity is maintained by an elevated stroke volume and a normal or somewhat low heart rate.11 30
Overall and regional resistances in different forms of hypertension in nonobese animals are generally increased.4 5 6 26 On the other hand, normotensive obese individuals usually demonstrate a decrease in overall resistance, as has been demonstrated in studies of obese adolescents8 and adults.3 30 The effect of obesity-associated hypertension on peripheral resistance varies depending on the predominant abnormality, with some subjects demonstrating decreased overall and regional peripheral resistances3 4 14 31 and others demonstrating increased overall resistance.3 4 25
The present study demonstrated that obesity-associated hypertension was associated with an 18% decrease in overall resistance. The magnitude of the decrease in absolute overall resistance is similar to that noted in the dog model of obesity-associated hypertension.10 13 32 When resistance is normalized for body weight or body surface area, however, both the present study and a previous study of obesity-associated hypertension in dogs10 noted a 20% increase in resistance, whereas obese hypertensive humans have shown an increase of 37%.26 However, the data on regional resistances in obesity are not clear. Obesity-associated hypertension in dogs was not associated with a change in regional vascular resistance,14 whereas in obese adolescents a decrease in forearm vascular resistance has been noted.8 On an absolute basis we noted decreases in renal, left ventricular, and intestinal resistances. When resistance values were normalized for organ weight, there was a tendency toward an increase in renal resistance, but this value did not reach statistical significance. Normalized left ventricular and intestinal resistances were approximately 20% lower in obese rabbits, but this was not significant.
Increases in regional flow associated with obesity-associated hypertension might not be related to any hemodynamic abnormality but could be related to increases in organ size. Indeed, many of the increases in absolute organ flow seen in the present study were reduced or eliminated when flow was indexed to account for the increase in organ weight. In contrast to the present study Rocchini13 did not find an increase in organ weight in obese compared with lean dogs despite a significant increase in body weight and suggested33 that weight gain was therefore associated with regional hemodynamic abnormalities. This conclusion may be the result of (1) the short 6-week experimental period, which may be insufficient for producing significant increases in organ weight, (2) the relatively small weight gain reported (2.5 kg), or (3) the large inherent variability among animal subjects in the dog model. Using an 8- to 12-week period of obesity in the rabbit model, we were able to demonstrate increased organ weight in most tissues measured.
Studies of changes in organ weight as a result of obesity are limited. Most studies recognize cardiac hypertrophy as common in obesity11 18 30 33 ; this increase in heart weight in obesity was recognized as early as 1928.34 In a later review Alexander30 stated that the increase in heart weight is primarily in the left ventricle and that the kidneys were also somewhat larger and heavier in obese subjects. Our data in obese rabbits confirm organ hypertrophy in both the kidney and left ventricle and expand these observations to suggest increased organ weight in many other body organs as well. We have previously demonstrated in the rabbit that cardiac hypertrophy associated with obesity-associated hypertension is not related to fatty infiltration but is primarily due to hypertrophy,35 similar to results seen in humans36 and rats.37 We have also shown in this model that most of the obesity-associated increases in organ weight in the lungs and gastrocnemius muscle are lean mass.24 Similarly, the increase in weight in the renal parenchyma is almost exclusively lean mass and water; however, there are accumulations of fat in the renal sinus that may contribute to increased renal interstitial pressure and thus to the pathogenesis of obesity-associated hypertension.24 Finally, obesity-associated increases in liver weight are primarily due to increases in lean mass, and although there are significant increases in fat, fat still represents a small proportion of the weight of the organ.24
Adipose Tissue Flow
There have been several reports of decreases in normalized
flow18 19 and increases in normalized
resistance19 in adipose tissue in obese animals; our
results demonstrate a similar adaptation in adipose tissue in
obesity-associated hypertension. Early speculations were that
although flow to adipose tissue in obesity might be less per unit
weight of tissue, the increases in mass of the fat depots and the blood
supply to them might become sufficiently large to cause significant
increases in resting cardiac output.30 Accordingly, we
estimated total flow to the adipose mass in lean and obese rabbits
using a mean value of adipose flow measured in the present study
(0.125 and 0.045 mL/min per gram, respectively) and total fat mass
measured previously in this rabbit model (360 and 1900 g, respectively)
using the same dietary protocol, which resulted in similar increases in
body weight.24 This calculation assumed that all the fat
depots measured contributed equally to the total fat mass and that fat
depots not measured had comparable flows; nevertheless, it likely
provides a good estimation of the magnitude and direction of difference
in total adipose flow in the lean and obese groups. These calculations
yielded an approximate total adipose flow in lean and obese rabbits of
45 and 86 mL/min, respectively, representing an estimated
7% and 11%, respectively, of cardiac output. Although the 7%
estimate for the lean rabbits in the present study is slightly
higher than values measured previously,6 15 38 differences
in the animals' sex and/or body weight may account for the variation.
Thus, despite the reduced flow per gram in adipose tissue in the obese
rabbits, a greater absolute amount of the overall flow is directed to
adipose tissue by virtue of the large increase in fat mass; overall
resistance to the adipose mass would consequently be reduced.
Therefore, although most of the increase in cardiac output in obesity
is directed toward lean tissue, adaptations in flow and resistance in
adipose tissue of obese animals are also important in the
hemodynamics of the development of
obesity-associated hypertension.
In summary, our results demonstrate that obesity-associated hypertension in the rabbit is associated with increases in organ weight, an increase in cardiac output, and a decrease in overall peripheral resistance. Alterations in flow and resistance were most striking in the left ventricle, kidney, and adipose tissue. These results indicate that even relatively short periods of obesity are associated with marked overall and regional hemodynamic changes. These results also demonstrate that the rabbit model mimics many of the cardiovascular changes noted in obesity-associated hypertension in humans and other animal models. Thus, the rabbit model may prove useful in the study of nutritional, cardiovascular, and metabolic problems related to obesity-associated hypertension.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received March 27, 1995; first decision May 24, 1995; accepted June 21, 1995.
| References |
|---|
|
|
|---|
2. Schmieder R, Messerli FH. Obesity hypertension. Med Clin North Am. 1987;71:991-1001. [Medline] [Order article via Infotrieve]
3.
Messerli FH, Christie B, DeCarvalho JGR, Aristimuno
CG, Suarez DH, Dreslinski GR, Frohlich ED. Obesity and essential
hypertension: hemodynamics, intravascular volume,
sodium excretion and plasma renin activity. Arch Intern
Med. 1981;141:81-85.
4. Messerli FH, Sundgaard-Riise K, Reisin E, Dreslinski G, Dunn FG, Frohlich E. Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med. 1983;74:808-812. [Medline] [Order article via Infotrieve]
5. Ferrone RA, Walsh GM, Tsuchiya M, Frohlich ED. Comparison of hemodynamics in conscious spontaneous and renal hypertensive rats. Am J Physiol. 1979;236:H403-H408.
6. Bolt GR, Saxena PR. Systemic and regional hemodynamic characteristics of bilateral cellophane perinephritis hypertension in conscious rabbits. Clin Exp Hypertens A. 1983;5:885-901. [Medline] [Order article via Infotrieve]
7. Rocchini AP, Moorehead C, Wentz E, DeRemer S. Obesity-induced hypertension in the dog. Hypertension. 1987;9(suppl III):III-64-III-68.
8. Rocchini AP, Key J, Bondie D, Chico F, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321:580-585. [Abstract]
9. Mizelle HL, Edwards TC, Montani J-P. Abnormal cardiovascular responses to exercise during the development of obesity in dogs. Am J Hypertens. 1994;7:374-378. [Medline] [Order article via Infotrieve]
10.
Hall JE, Brands ME, Dixon WN, Smith MJ.
Obesity-induced hypertension: renal function and systemic
hemodynamics.
Hypertension. 1993;22:292-299.
11. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med. 1976;60:645-653. [Medline] [Order article via Infotrieve]
12.
Andersson OK, Fagerberg B, Hedner T. Importance
of dietary salt in the hemodynamic adjustment to weight
reduction in obese hypertensive men.
Hypertension. 1984;6:814-819.
13.
Rocchini AP. The influence of obesity in
hypertension. News Physiol Sci. 1990;5:245-249.
14. Martin M, Rocchini AP, Bondie D, DeRemer S, Moorehead C. Hemodynamic alteration in obesity. Circulation. 1988;78(suppl IV):IV-319. Abstract.
15. Van Boom M, Saxena PR. Systemic and regional haemodynamics in experimental renal hypertension in conscious rabbits. Clin Exp Pharmacol Physiol. 1980;7:627-634. [Medline] [Order article via Infotrieve]
16. Neutze JM, Wyler F, Rudolph AM. Use of radioactive microspheres to assess distribution of cardiac output in rabbits. Am J Physiol. 1968;215:486-495.
17. Nishiyama K, Nishiyama A, Frohlich ED. Regional blood flow in normotensive and spontaneously hypertensive rats. Am J Physiol. 1976;230:691-698.
18.
West DB, Prinz WA, Francendese AA, Greenwood
MRC. Adipocyte blood flow is decreased in obese Zucker
rats. Am J Physiol. 1987;253:R228-R233.
19. Crandall DL, Goldstein BM, Lizzo FH, Gabel RA, Cervoni P. Hemodynamics of obesity: influence of pattern of adipose tissue cellularity. Am J Physiol. 1986;251:R314-R319.
20. Lesser GT, Deutsch S. Measurement of adipose tissue blood flow and perfusion in man by uptake of 85Kr. J Appl Physiol. 1967;23:612-630.
21. Harkness JE. Rabbit husbandry and medicine. Vet Clin North Am. 1987;17:1019-1044.
22. Montani J-P, Mizelle HL, Adair TH, Guyton AC. Regulation of cardiac output during aldosterone hypertension. J Hypertens. 1989;7(suppl 6):S206-S207.
23. Stanek KA, Coleman TG, Smith TL, Murphy WR. Two hemodynamic problems commonly associated with the microsphere techniques for measuring regional blood flow in rats. J Pharmacol Methods. 1985;13:117-124. [Medline] [Order article via Infotrieve]
24. Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and body composition in hypertensive obese rabbits. Int J Obes. In press.
25.
Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo
EL. Hypertension in obese patients: hemodynamic
and volume studies. Hypertension. 1982;4:84-92.
26. Raison J, Achimastos A, Bouthier J, London G, Safer M. Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol. 1983;51:165-170. [Medline] [Order article via Infotrieve]
27. Reisin E, Suarez DH, Frohlich ED. Haemodynamic changes associated with obesity and high blood pressure in rats with ventromedial hypothalamic lesions. Clin Sci. 1980;59:397s-399s.
28. Ventura HO, Reisin E, Pegram BL, Wilson JR, Frohlich ED. Body composition and its relation to systemic haemodynamics, fluid volume partitions and energy utilization in rats with bilateral ventromedial hypothalamic lesions. J Hypertens. 1985;3:189-194. [Medline] [Order article via Infotrieve]
29. Reisin E, Frohlich ED, Messerli FH, Dreslinski GR, Dunn FG, Jones MM, Batson HM. Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med. 1983;98:315-319.
30. Alexander JK. Obesity and the circulation. Mod Concepts Cardiovasc Dis.. 1963;32:799-803. [Medline] [Order article via Infotrieve]
31. Dustan HP. Mechanisms of hypertension associated with obesity. Ann Intern Med. 1983;98:860-864.
32.
Rocchini AP, Moorehead CP, DeRemer S, Bondie D.
Pathogenesis of weight-related changes in blood pressure in
dogs. Hypertension. 1989;13:922-928.
33. Rocchini AP. Cardiovascular regulation in obesity-induced hypertension. Hypertension. 1992;19(suppl I):I-56-I-60.
34. Smith HL. The relation of the weight of the heart to the weight of the body and of the weight of the heart to age. Am Heart J. 1928;4:79-93.
35. Mizelle HL, Dwyer TM, Grady AW, Reinhart GA, Montani J-P, Cockrell D, Carroll JF, Diveki K. Hypertension and cardiac hypertrophy in a new animal model of obesity. J Mol Cell Cardiol. 1995;27:A29. Abstract.
36.
Amad KH, Brennan JC, Alexander JK. The cardiac
pathology of chronic exogenous obesity.
Circulation. 1965;32:740-745.
37. Paradise NF, Pilati CF, Payne WR, Finkelstein JA. Left ventricular function of the isolated, genetically obese rat's heart. Am J Physiol. 1985;248:H438-H444.
38.
Lublin A, Wolfenson D, Berman A. Sex differences
in blood flow distribution of normothermic and
heat-stressed rabbits. Am J Physiol. 1995;268:R66-R71.
This article has been cited by other articles:
![]() |
L. Xiang and R. L. Hester Adipocyte-derived factor reduces vasodilatory capability in ob-/ob- mice Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H689 - H695. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Michaels, G. A. Eppel, S. L. Burke, G. A. Head, J. Armitage, J. F. Carroll, S. C. Malpas, and R. G. Evans Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2009; 296(6): R1889 - R1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-j. Zhang, D. L. Chinkes, A. Aarsland, D. N. Herndon, and R. R. Wolfe Lipid Metabolism in Diet-Induced Obese Rabbits Is Similar to That of Obese Humans J. Nutr., March 1, 2008; 138(3): 515 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Carroll, W. J. Zenebe, and T. B. Strange Cardiovascular Function in a Rat Model of Diet-Induced Obesity Hypertension, July 1, 2006; 48(1): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M Boustany, D. R. Brown, D. C. Randall, and L. A Cassis AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R181 - R186. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text] |
||||
![]() |
J. E. Hall The Kidney, Hypertension, and Obesity Hypertension, March 1, 2003; 41(3): 625 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF] |
||||
![]() |
D. A. PRICE, L. E. PORTER, M. GORDON, N. D. L. FISHER, J. M. F. DE'OLIVEIRA, L. M. B. LAFFEL, D. R. PASSAN, G. H. WILLIAMS, and N. K. HOLLENBERG The Paradox of the Low-Renin State in Diabetic Nephropathy J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2382 - 2391. [Abstract] [Full Text] |
||||
![]() |
R. A. Khalil, J. K. Crews, J. F. Carroll, and J. E. Hall Enhanced Vascular Reactivity and Ca2+ Entry With Low-Salt Diet : Effect of Obesity Hypertension, October 1, 1999; 34(4): 882 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Carroll, R. L. Summers, D. J. Dzielak, K. Cockrell, J.-P. Montani, and H. L. Mizelle Diastolic Compliance Is Reduced in Obese Rabbits Hypertension, March 1, 1999; 33(3): 811 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Porter and N. K. Hollenberg Obesity, Salt Intake, and Renal Perfusion in Healthy Humans Hypertension, July 1, 1998; 32(1): 144 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Carroll, A. E. Jones, R. L. Hester, G. A. Reinhart, K. Cockrell, and H. L. Mizelle Reduced Cardiac Contractile Responsiveness to Isoproterenol in Obese Rabbits Hypertension, December 1, 1997; 30(6): 1376 - 1381. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |